Bipolar Bozukluk ve Romatoid Artrit İlişkisi

Year 2022, Volume: 14 Issue: 2, 131 - 142, 30.06.2022

Melike Mandacı , Aslı Sarandöl , Cengiz Akkaya

https://doi.org/10.18863/pgy.921569

Abstract

Romatoid artrit, sinovit, sistemik inflamasyon, artrit ve vaskülit, anemi, mononörit, pulmoner fibrozis gibi eklem dışı sistem tutulumu ile karakterize olan zamanında ve yeterli tedavi edilmezse eklem destruksiyonuna, eklem hareketlerinin kısıtlanmasına, hastanın yaşam kalitesinin bozulmasına neden olabilecek kronik bir otoimmün hastalıktır. Romatoid artrit hastalarında eklem bulgularının yanı sıra klinik tabloya bilişsel işlev bozukluğu, davranış değişiklikleri ve duygudurum değişiklikleri gibi nöropsikiyatrik belirtiler de eşlik edebilir. Romatoid artrit hastalarında nöroinflamatuar sürecin, plazmadaki proinflamatuar sitokin düzeylerinde artışın, uzun süre kullanılan ilaçların yan etkilerinin, hastalıkla birlikte oluşan yeti yitiminin ve olası ortak gen bölgelerinin bu belirtilere neden olabileceği düşünülmektedir. Romatoid artrit hastalarında psikiyatrik semptom ve bozukluklarla ilgili giderek artan sayıda çalışmalar yayınlanmaktadır. Özellikle anksiyete bozuklukları ve major depresif bozukluk ile ilişkisine odaklanan birçok çalışma mevcuttur. Bipolar bozukluk etiyolojisinde immün fonksiyonlarda bozulmanın yer aldığına ilişkin giderek artan sayıda çalışma bulunmaktadır. Bipolar bozukluk hastalarının plazmalarında sitokin düzeylerinde değişiklikler görülmesi bu görüşü destekler niteliktedir. Çeşitli otoimmün hastalıklarla bipolar bozukluk arasındaki ilişki baraştırılmaya devam edilmektedir. Romatolojik hastalığı olan bireylerde, psikiyatrik eş tanılar açısından dikkatli olunması hastaların tedaviye uyumu ve klinik seyir açısından önemlidir.

Keywords

romatoid artrit, inflamasyon, psikonöroimmünoloji, bipolar bozukluk

Relationship between Bipolar Disorder and Rheumatoid Arthritis

Abstract

Rheumatoid arthritis is a chronic autoimmune disease that is characterized by synovitis, systemic inflammation, arthritis and vasculitis, anemia, mononeuritis, pulmonary fibrosis, and can cause joint destruction, limitation of joint movements and impairment of the patient's quality of life if not treated in right time and adequate manner. In addition to joint symptoms, neuropsychiatric symptoms such as cognitive dysfunction, behavioral changes, and mood changes may accompany rheumatoid arthritis patients. It is thought that neuroinflammatory process in rheumatoid arthritis patients, increase in proinflammatory cytokine levels in plasma; side effects of drugs used for a long time, disability that occurs with the disease, and possible common gene regions may cause these symptoms. An increasing number of studies are being published on psychiatric symptoms and disorders in patients with rheumatoid arthritis. There are many studies focusing especially on its relationship with anxiety disorders and major depressive disorder. There are increasing numbers of studies showing that the impairment of immune functions is involved in the etiology of bipolar disorder. The changes in cytokine levels in the plasma of bipolar disorder patients supports this argument. The relationship between various autoimmune diseases and bipolar disorder continues to be examined. In people with rheumatological diseases, it is important to be careful in psychiatric comorbidities in terms of patient compliance and clinical course.

Keywords

rheumatoid arthritis, inflammation, psychoneuroimmunology, bipolar disorder

References

• Abbott NJ, Ronnback L, Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 2006; 7: 41–53.
• Arias I, Sorlozano A, Villegas E, de Dios Luna J, McKenney K, Cervilla J, Gutierrez B, Gutierrez J. Infectious agents associated with schizophrenia: a meta-analysis. Schizophr Res. 2012 Apr;136(1-3):128-36. doi: 10.1016/j.schres.2011.10.026. Epub 2011 Nov 21. PMID: 22104141.
• Austin M, Tan YCJ. Mania associated with infliximab. Aust N Z J Psychiatry 2012; 46: 684–685.
• Belt N, Kronholm E, Kauppi M. Sleep problems in fibromyalgia and rheumatoid arthritis compared with the general population. Clin. Exp. Rheumatol. 2009; 27, 35
• Belvederi Murri M, Prestia D, Mondelli V, Pariante C, Patti S, Olivieri B, Amore M. The HPA axis in bipolar disorder: systematic review and meta-analysis. Psychoneuroendocrinology 2016; 63, 327–342. https://doi.org/10.1016/j.psyneuen.2015. 10.014.
• Benros ME, Waltoft BL, Nordentoft M, Ostergaard SD, Eaton WW, Krogh J, Mortensen PB. Autoimmune diseases and severe infections as risk factors for mood disorders: a nationwide study. JAMA Psychiatry. 2013 Aug;70(8):812-20. doi: 10.1001/jamapsychiatry.2013.1111. PMID: 23760347.
• Berk M, Kapczinski F, Andreazza AC, Dean OM, Giorlando F, Maes M, Malhi GS. Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci. Biobehav. Rev. 2011; 35 (3), 804–817. https://doi.org/10.1016/j.neubiorev.2010.10.001
• Bolanos SH, Khan DA, Hanczyc M, Bauer MS, Dhanani N, Brown ES. Assessment of mood states in patients receiving long-term corticosteroid therapy and in controls with patient-rated and clinician-rated scales. Ann Allergy Asthma Immunol. 2004 May;92(5):500-5. doi: 10.1016/S1081-1206(10)61756-5. PMID: 15191017.
• Brietzke E, Kapczinski F. TNF-α as a molecular target in bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 2008; 32: 1355–1361.
• Brietzke E, Stertz L, Fernandes BS, Kauer-Sant'anna M, Mascarenhas M, Escosteguy Vargas A, Chies JA, Kapczinski F. Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder. J Affect Disord. 2009 Aug;116(3):214-7. doi: 10.1016/j.jad.2008.12.001. Epub 2009 Feb 28. PMID: 19251324.
• Brietzke E, Lafer B. Induction of manic switch by the tumor necrosis factor-α antagonist infliximab. Psychiatry Clin Neurosci 2010; 64: 442–443.
• Bruce, T. O. Comorbid depression in rheumatoid arthritis: pathophysiology and clinical implications. Curr. Psychiatry. Rep. 2008; 10, 258–264
• Ceïde ME, Rosenberg PB. Brief Manic episode after Rituximab Treatment of limbic encephalitis. J Neuropsychiatry Clin Neurosci 2011; 23: E8.
• Chandarana PC, Eals M, Steingart AB, Bellamy N, Allen S. The detection of psychiatric morbidity and associated factors in patients with rheumatoid arthritis. Can J Psychiatr 1987; 32:356–361
• Chugani DC, Ackermann RF, Phelps ME. In vivo [3H]spiperone binding: Evidence for accumulation in corpus striatum by agonist-mediated receptor internalization. J Cereb Blood Flow Metab 1988; 8: 291–303.
• Corfield EC, Martin NG, Nyholt DR. Co-occurrence and symptomatology of fatigue and depression. Compr Psychiatry. 2016 Nov;71:1-10. doi: 10.1016/j.comppsych.2016.08.004. Epub 2016 Aug 9. PMID: 27567301.
• Covic T, Cumming SR, Pallant JF, Manolios N, Emery P, Conaghan PG, Tennant A. Depression and anxiety in patients with rheumatoid arthritis: prevalence rates based on a comparison of the Depression, Anxiety and Stress Scale (DASS) and the hospital, Anxiety and Depression Scale (HADS). BMC Psychiatry 2012; 24;12:6. doi: 10.1186/1471-244X-12-6. PMID: 22269280; PMCID: PMC3285517.
• Cronin MJ . Some calcium and lysosome antagonists inhibit 3H-spiperone binding to the porcine anterior pituitary. Life Sci 1982; 30: 1385–1389.
• Cross M, Smith E, Hoy D, Carmona L, Wolfe F, Vos T, March L, The global burden of rheumatoid arthritis: estimates from the global burden of disease 2010 study. Ann. Rheum. Dis. 2014; 73 (7), 1316. https://doi.org/10.1136/annrheumdis2013-204627.
• Cutolo M, Kitas GD,van Riel PL. Burden of disease in treated rheumatoid arthritis patients: going beyond the joint. Semin. Arthritis Rheum. 2014; 43, 479–488
• Dickens C, McGowan L, Clark-Carter D, Creed F. Depression in rheumatoid arthritis: a systematic review of the literature with meta-analysis. Psychosom Med 2002; 64: 52–60.
• Drew JF. Concerning the side effects of antimalarial drugs used in the extended treatment of rheumatic diseases. Med J Aust. 1962;49:618–620.
• Eaton WW, Byrne M, Ewald H, Mors O, Chen CY, Agerbo E, Mortensen PB. Association of schizophrenia and autoimmune diseases: linkage of Danish national registers. Am J Psychiatry. 2006 Mar;163(3):521-8. doi: 10.1176/appi.ajp.163.3.521. PMID: 16513876.
• Eaton WW, Pedersen MG, Nielsen PR, Mortensen PB. Autoimmune diseases, bipolar disorder, and non-affective psychosis. Bipolar Disord. 2010; 12 (6), 638–646.
• Edwards RR, Cahalan C, Mensing G, Smith M, Haythornthwaite JA. Pain, catastrophizing, and depression in the rheumatic diseases. Nat. Rev. Rheumatol. 2011; 7, 216–224
• Englbrecht M, Gossec L, DeLongis A, Scholte-Voshaar M, Sokka T, Kvien TK, Schett G. The impact of coping strategies on mental and physical well-being in patients with rheumatoid arthritis. Semin Arthritis Rheum. 2012 Feb;41(4):545-55. doi: 10.1016/j.semarthrit.2011.07.009. PMID: 22340997.
• Fifield J, McQuillan J, Tennen H, Sheehan TJ, Reisine S, Hesselbrock V, Rothfield N. History of affective disorder and the temporal trajectory of fatigue in rheumatoid arthritis. Ann Behav Med. 2001 Winter;23(1):34-41. doi: 10.1207/S15324796ABM2301_6. PMID: 11302354.
• Firestein GS, McInnes IB. Immunopathogenesis of rheumatoid arthritis. Immunity 2017; 46: 183–96.
• Goldsmith DR, Rapaport MH, Miller BJ. A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression. Mol Psychiatry. 2016 Dec;21(12):1696-1709. doi: 10.1038/mp.2016.3. Epub 2016 Feb 23. PMID: 26903267; PMCID: PMC6056174.
• Ho RC, Fu EH, Chua AN, Cheak AA, Mak A. Clinical and psychosocial factors associated with depression and anxiety in Singaporean patients with rheumatoid arthritis. Int J Rheum Dis 2011; 14:37–47
• Hsu WH, Chiu NY, Huang SS. Hydroxychloroquine-induced acute psychosis in a systemic lupus erythematosus female. Acta Neuropsychiatrica 2011;23:318–319. doi: 10.1111/j.1601-5215.2011.00575.x.
• Imran MY, Khan SEA, Ahmad NM, Raja SF, Saeed MA, Haider II. Depression in rheumatoid arthritis and its relation to disease activity. Pak J Med Sci 2015; 31:393–397 .
• Isgren A, Jakobsson J, Pålsson E, Ekman CJ, Johansson AG, Sellgren C, Blennow K, Zetterberg H, Landén M. Increased cerebrospinal fluid interleukin-8 in bipolar disorder patients associated with lithium and antipsychotic treatment. Brain Behav Immun 2015 Jan; 43:198-204. doi: 10.1016/j.bbi.2014.10.001. Epub 2014 Oct 14. PMID: 25451615.
• Isik A, Koca SS, Ozturk A, Mermi O. Anxiety and depression in patients with rheumatoid arthritis. Clin. Rheumatol. 2007; 26, 872–878
• Jakobsson J, Bjerke M, Sahebi S, Isgren A, Ekman CJ, Sellgren C, Olsson B, Zetterberg H, Blennow K, Pålsson E, Landén M. Monocyte and microglial activation in patients with mood-stabilized bipolar disorder. J Psychiatry Neurosci. 2015 Jul; 40(4):250-8. doi: 10.1503/jpn.140183. PMID: 25768030; PMCID: PMC4478058.
• Joharatnam N, McWilliams DF, Wilson D, Wheeler M, Pande I, Walsh DA. A cross-sectional study of pain sensitivity, disease-activity assessment, mental health, and fibromyalgia status in rheumatoid arthritis. Arthritis Res Ther. 2015 Jan 20;17(1):11. doi: 10.1186/s13075-015-0525-5. PMID: 25600850; PMCID: PMC4363056.
• Kanju PM, Parameshwaran K, Vaithianathan T. Lysosomal dysfunction produces distinct alterations in synaptic alpha-amino-3-hydroxy-5-methylisoxazolepropionic acid and N-methyl-D-aspartate receptor currents in hippocampus. J Neuropathol Exp Neurol 2007; 66: 779–788.
• Kaufman KR . Etanercept, anticytokines and mania. Int Clin Psychopharmacol 2005; 20: 239–241.
• Kekow J, Moots R, Khandker R, Melin J, Freundlich B, Singh A. Improvements in patient-reported outcomes, symptoms of depression and anxiety, and their association with clinical remission among patients with moderate-to-severe active early rheumatoid arthritis. Rheumatology (Oxford) 2011; 50:401–409
• Kelley WN, Harris ED Jr, Ruddy S, Sledge CB. Textbook of rheumatology. Altıncı baskı. Philadelphia: Saunders Company; 2001. p. 864–5.
• Kojima M, Kojima T, Suzuki S, Oguchi T, Oba M, Tsuchiya H, Sugiura F, Kanayama Y, Furukawa TA, Tokudome S, Ishiguro N. Depression, inflammation, and pain in patients with rheumatoid arthritis. Arthritis Rheum 2009; 61:1018–1024
• Lampa J, Westman M, Kadetoff D, Agréus AN, Le Maître E, Gillis-Haegerstrand C, Svensson CI. Peripheral inflammatory disease associated with centrally activated IL-1 system in humans and mice. Proc. Natl. Acad. Sci. U.S.A. 2012; 109 (31), 12728–12733. https://doi.org/10.1073/pnas.1118748109.
• Manzo C, Gareri P, Castagna A. Psychomotor Agitation Following Treatment with Hydroxychloroquine. Drug Saf - Case Rep 2017; 4, 6 https://doi.org/10.1007/s40800-017-0048-x
• Matcham F, Rayner L, Steer S, Hotopf M. The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis. Rheumatology 2013; 52: 2136–48.
• Miller AH, Raison CL. The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat. Rev. Immunol. 2016; 16 (1), 22–34. https://doi.org/10.1038/nri.2015.5.
• Miller BJ, Buckley P, Seabolt W, Mellor A, Kirkpatrick B. Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol. Psychiatry 2011; 70 (7), 663–671.
• Modabbernia A, Taslimi S, Brietzke E, Ashrafi M. Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies. Biol. Psychiatry 2013; 74 (1), 15–25.
• Mok C, Lok E, Cheung E. Concurrent psychiatric disorders are associated with significantly poorer quality of life in patients with rheumatoid arthritis. Scand. J. Rheumatol. 2012; 41, 253–259
• Munkholm K, Vinberg M, Vedel Kessing L. Cytokines in bipolar disorder: a systematic review and meta-analysis. J. Affect. Disord. 2013; 144 (1–2), 16–27. https://doi. org/10.1016/j.jad.2012.06.010.
• Najjar S, Pearlman DM, Alper K, Najjar A, Devinsky O. Neuroinflammation and psychiatric illness. J Neuroinflammation 2013; 10:43.
• Nakajima A, Kamitsuji S, Saito A, Tanaka E, Nishimura K, Horikawa N, Ozaki N, Tomatsu T, Hara M, Kamatani N, Yamanaka H. Disability and patient's appraisal of general health contribute to depressed mood in rheumatoid arthritis in a large clinical study in Japan. Mod Rheumatol. 2006;16(3):151-7. doi: 10.1007/s10165-006-0475-5. PMID: 16767553.
• Nikolaus S, Bode C, Taal E, de Laar MA. Fatigue and factors related to fatigue in rheumatoid arthritis: a systematic review. Arthritis Care Res. (Hoboken ) 2013; 65, 1128–1146
• Öncü J, Başoğlu F, Kuran, B. A comparison of impact of fatigue on cognitive, physical, and psychosocial status in patients with fibromyalgia and rheumatoid arthritis. Rheumatol. Int. 2013; 33, 3031–3037
• Pålsson E, Jakobsson J, Södersten K, Fujita Y, Sellgren C, Ekman CJ, Ågren H, Hashimoto K, Landén M. Markers of glutamate signaling in cerebrospinal fluid and serum from patients with bipolar disorder and healthy controls. Eur Neuropsychopharmacol. 2015 Jan; 25(1):133-40. doi: 10.1016/j.euroneuro.2014.11.001. Epub 2014 Nov 13. PMID: 25482684.
• Pollard L, Choy E, Gonzalez J, Khoshaba B, Scott D. Fatigue in rheumatoid arthritis reflects pain, not disease activity. Rheumatology (Oxford) 2006; 45, 885–889
• Qiu XJ, Zhang XL, Cai LS, Yan C, Yu L, Fan J, Zhang RW, Huang JW, Duan XW. Rheumatoid arthritis and risk of anxiety: a meta-analysis of cohort studies. Clin Rheumatol. 2019 Aug;38(8):2053-2061. doi: 10.1007/s10067-019-04502-8. Epub 2019 Mar 28. PMID: 30924010.
• Rao JS, Harry GJ, Rapoport SI, Kim HW. Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients. Mol. Psychiatry 2010;15 (4), 384–392. https://doi.org/10.1038/mp.2009.47.
• Rege S, Hodgkinson SJ. Immune dysregulation and autoimmunity in bipolar disorder: synthesis of the evidence and its clinical application. Aust. N. Z. J. Psychiatry 2013; 47 (12), 1136–1151. https://doi.org/10.1177/0004867413499077
• Rosenblat JD, McIntyre RS. Bipolar disorder and immune dysfunction: epidemiological findings, proposed pathophysiology and clinical implications. Brain Sci. 2017; 7 (11), 144. https://doi.org/10.3390/brainsci7110144.
• Rupp I, Boshuizen HC, Jacobi CE, Dinant H J, van den Bos GA. Impact of fatigue on health- related quality of life in rheumatoid arthritis. Arthritis Care Res. (Hoboken) 2004; 51, 578–585
• Sasayama D, Hattori K, Wakabayashi C, Teraishi T, Hori H, Ota M, Yoshida S, Arima K, Higuchi T, Amano N, Kunugi H. Increased cerebrospinal fluid interleukin-6 levels in patients with schizophrenia and those with major depressive disorder. J Psychiatr Res. 2013 Mar; 47(3):401-6. doi: 10.1016/j.jpsychires.2012.12.001. Epub 2013 Jan 3. PMID: 23290488.
• Scharloo M, Kaptein AA, Weinman J, Hazes JM, Willems LN, Bergman W, Rooijmans HG. Illness perceptions, coping and functioning in patients with rheumatoid arthritis, chronic obstructive pulmonary disease and psoriasis. J Psychosom Res. 1998 May;44(5):573-85. doi: 10.1016/s0022-3999(97)00254-7. PMID: 9623878.
• Schatzberg AF, Nemeroff CB. Textbook of psychopharmacology. Dördüncü baskı. Washington: The American Psychiatric Publishing Inc, 2009.
• Scott DL, Wolfe F, Huizinga TWJ. Rheumatoid arthritis. Lancet 2010; 376 (9746), 1094–1108. https://doi.org/10.1016/S0140-6736(10)60826-4.
• Söderlund J, Olsson SK, Samuelsson M, Walther-Jallow L, Johansson C, Erhardt S, Engberg G. Elevation of cerebrospinal fluid interleukin-1ß in bipolar disorder. J. Psychiatry Neurosc. 2011; 36 (2), 114–118. https://doi.org/10.1503/jpn.100080.
• Straub RH, Cutolo M. Involvement of the hypothalamic–pituitary–adrenal/gonadal axis and the peripheral nervous system in rheumatoid arthritis: viewpoint based on a systemic pathogenetic role. Arthritis Rheum. 2001; 44, 493–507
• Straub RH. Rheumatoid arthritis: stress in RA: a trigger of proinflammatory pathways? Nat. Rev. Rheumatol. 2014; 10, 516–518
• Sullivan MJ, Bishop SR, Pivik J. The pain catastrophizing scale: development and validation. Psychol. Assess. 1995; 7, 524
• Szekanecz Z, Vegvari A, Szabo Z, Koch AE. Chemokines and chemokine receptors in arthritis. Front Biosci 2010; 2: 153–67.
• Torrey EF, Yolken RH . The schizophrenia-rheumatoid arthritis connection: infectious, immune, or both? Brain Behav Immun 2001; 15: 401–410.
• Uhlig T, Moe RH, Kvien TK. The burden of disease in rheumatoid arthritis. Pharmacoeconomics 2014; 32 (9), 841–851. https://doi.org/10.1007/s40273-014-0174-6.
• Van’t LH, Verdurmen J, Ten HM, van Dorsselaer S, Beekman A, de Graaf R. The association between arthritis and psychiatric disorders; results from a longitudinal population- based study. J Psychosom Res 2010; 68:187–193
• Waraich P, Goldner EM, Somers JM, Hsu L. Prevalence and incidence studies of mood disorders: a systematic review of the literature. Can J Psychiatry 2004; 49: 124–38.
• Warrington TP, Bostwick JM. Psychiatric adverse effects of corticosteroids. Mayo Clin Proc. 2006 Oct;81(10):1361-7. doi: 10.4065/81.10.1361. PMID: 17036562.
• Wolfe F, Michaud K. Predicting depression in rheumatoid arthritis: the signal importance of pain extent and fatigue, and comorbidity. Arthritis Care Res. (Hoboken) 2009;61, 667–673
• Zautra AJ, Burleson MH, Smith CA, Blalock SJ, Wallston KA, DeVellis RF, DeVellis BM, Smith TW. Arthritis and perceptions of quality of life: an examination of positive and negative affect in rheumatoid arthritis patients. Health Psychol. 1995 Sep;14(5):399-408. doi: 10.1037//0278-6133.14.5.399. PMID: 7498110.
• Zetterberg H, Jakobsson J, Redsäter M, Andreasson U, Pålsson E, Ekman CJ, Sellgren C, Johansson AG, Blennow K, Landén M. Blood-cerebrospinal fluid barrier dysfunction in patients with bipolar disorder in relation to antipsychotic treatment. Psychiatry Res. 2014 Jul; 30;217(3):143-6. doi: 10.1016/j.psychres.2014.03.045. Epub 2014 Apr 5. PMID: 24745469.